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Abstract Evidence is accumulating that intracellular animal
lectins play important roles in quality control and glycoprotein
sorting along the secretory pathway. Calnexin and calreticulin in
conjunction with associated chaperones promote correct folding
and oligomerization of many glycoproteins in the endoplasmic
reticulum (ER). The mannose lectin ERGIC-53 operates as a
cargo receptor in transport of glycoproteins from ER to Golgi
and the homologous lectin VIP36 may operate in quality control
of glycosylation in the Golgi. Exit from the Golgi of lysosomal
hydrolases to endosomes requires mannose 6-phosphate receptors
and exit to the apical plasma membrane may also involve traffic
lectins. Here we discuss the features of these lectins and their role
in glycoprotein traffic in the secretory pathway. ß 2000 Fed-
eration of European Biochemical Societies. Published by Else-
vier Science B.V. All rights reserved.
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1. Introduction
Lectins are de¢ned as non-enzymatic, sugar binding pro-
teins. While plant lectins have been invaluable tools in the
molecular analysis of animal glycoproteins for decades, ani-
mal lectins have raised interest only recently. A long-standing
enigma has been the role of N-linked glycans attached to
many proteins in the endoplasmic reticulum (ER) and their
co- and posttranslational remodelling along the secretory
pathway. The early discovery that one of these glycan mod-
i¢cations, mannose 6-phosphate (Man-6-P), serves as a lyso-
somal targeting signal that is recognized by mannose 6-phos-
phate receptors (MPRs [1]) has led to the notion that lectins
may play more general roles in exocytotic protein tra⁄cking.
Only recently though has there been substantial evidence in
support of this notion. Here we discuss the role of intracellu-
lar lectins in exocytotic glycoprotein transport and their role
in understanding the mechanisms underlying protein tra⁄c in
the secretory pathway.
2. ER quality control
During and after translocation into the ER many newly
synthesized secretory proteins acquire posttranslational mod-
i¢cations, including N-glycosylation, as well as chaperone-as-
sisted folding and oligomerization that lead to a transport-
competent conformation. Elaborate quality control mecha-
nisms sort incorrectly from correctly folded proteins in the
ER [2]. Incorrectly folded proteins are retained and, if folding
is unsuccessful, degraded by the proteasome after retrotrans-
location into the cytosol [3]. In both the folding and degra-
dation processes lectins play an important part.
Two homologous lectins are known to be localized in the
ER, the type I membrane protein calnexin and the soluble
protein calreticulin [4^6] (Table 1). Both proteins share the
same glycan speci¢city and bind monoglucosylated N-linked
oligosaccharides with a Glc1Man9GlcNAc2 structure [7]. The
terminal glucose is crucial for binding but some mannose
residues also contribute to the speci¢city of oligosaccharide
binding. Calnexin and calreticulin operate as chaperones in
the quality control of newly synthesized glycoproteins in
two opposing ways. They ensure that correctly folded glyco-
proteins leave the ER, but they can also mediate glycoprotein
degradation in cases where correct protein folding is impos-
sible. The lectin-assisted glycoprotein folding involves a re-
markable cycle of de- and reglucosylation [2,4] (Fig. 1). Newly
synthesized glycoproteins carrying three glucose residues on
each glycan are co-translationally trimmed by the sequential
action of ER glucosidases I and II. Monoglucosylated glyco-
proteins bind calnexin and/or calreticulin and are presented to
the thiol oxidoreductase chaperone ERp 57 [8] and presum-
ably other chaperones. Glucosidase II then removes the re-
maining glucose residue that abolishes lectin^glycoprotein in-
teraction. If the glycoprotein is correctly folded it will leave
the ER. If not, it will be recognized by the ER enzyme UDP-
glucose:glycoprotein glucosyltransferase (GT) and reglucosy-
lated, thereby allowing it to reassociate with the quality con-
trol machinery. GT operates as a folding sensor, because it
recognizes glycoproteins in their non-native but not in their
native conformation [9]. GT is able to distinguish between
di¡erent non-native conformations with a distinct preference
for partially structured folding intermediates [10]. The deglu-
cosylation and reglucosylation cycle continues until correct
folding is achieved. While there is general agreement that
the lectin function of calnexin and calreticulin is important
for glycoprotein folding, the question of whether the two pro-
teins function solely as lectins (‘lectin-only’ hypothesis [4]) or
both as a lectin and as a classic chaperone (‘dual binding’
model [11]) remains controversial. In the dual binding model
the lectins would possess a second site that binds to polypep-
tide segments of unfolded or partially folded proteins. Recent
in vitro studies with puri¢ed components lend support to this
notion. Both lectins were found to prevent aggregation of
glycoproteins bearing monoglucosylated oligosaccharides but
also proteins lacking N-glycans and this e¡ect was enhanced
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by ATP [12,13]. It remains to be shown if the non-lectin
function of calreticulin and calnexin is productive in vivo.
Calreticulin was also isolated from Golgi fractions of rat
liver and it co-fractionated with Golgi endomannosidase to
comparable amounts [14]. It is possible therefore that in
some cells calreticulin-mediated quality control includes
post-ER compartments in which deglucosylation to dissociate
the chaperone^glycoprotein complexes would involve endo-
mannosidase instead of glucosidase II.
Calnexin appears to also play a role in glycoprotein degra-
dation. Proteasomal degradation of misfolded human K1-anti-
trypsin requires the physical interaction with calnexin [15],
and mannose trimming by ER mannosidase I in conjunction
with GT-mediated reglucosylation, leading to monoglucosy-
lated Man8GlcNAc2, delays dissociation of misfolded K1-anti-
trypsin from calnexin. This suggests that calnexin in conjunc-
tion with mannosidase I selects misfolded glycoproteins for
degradation by the proteasome (Fig. 1). It is not known if
calreticulin can also participate in the degradative pathway.
ER degradation of misfolded carboxypeptidase Y in the
yeast Saccharomyces cerevisiae is determined by a similar ol-
igosaccharide structure that requires the action of ER man-
nosidase I, and an ER lectin was postulated to speci¢cally
recognize the Man8GlcNAc2 structure and target the mal-
folded protein to the degradation pathway [16]. However,
the unknown lectin is neither calnexin nor calreticulin since
the calnexin/calreticulin cycle of reglucosylation has not been
found in S. cerevisiae [17,18].
After exit from the calreticulin/calnexin cycle correctly
folded glycoproteins can undergo some mannose trimming
by ER mannosidases I and II leading to Man7ÿ8GlcNAc2
glycans [19].
3. From ER to ERGIC and Golgi
Correctly folded proteins, also termed ‘cargo’, are sorted
from ER-resident proteins and leave the ER at the transition-
al elements both near the Golgi and in more peripheral sites
where they are packaged into COPII-coated vesicles [20]. The
polymerization of the COPII coat onto ER membranes drives
vesicle budding in vitro. This occurs by sequential binding of
the COPII components Sar1 GTPase and the heterodimeric
protein complexes Sec23p/Sec24p and Sec13p/Sec31p [21]. The
incorporation of cargo is believed to be selective, i.e. signal-
mediated [22^24], and perhaps non-selective to some extent,
i.e. by bulk £ow [25,26]. Soon after formation, COPII vesicles
shed their coat and, according to the maturation hypothesis,
are believed to fuse with one another to form the ER^Golgi
intermediate compartment (ERGIC). According to the stable
compartment model the vesicles would fuse with preexisting
ERGIC elements. The ERGIC is a collection of highly mobile
tubulovesicular clusters located both near the Golgi and in the
cell periphery. It is the ¢rst sorting station for forward (ante-
rograde) and backward (retrograde) tra⁄c [27,28]. The 53
kDa type I lectin membrane protein ERGIC-53 (Table 1) is
the most popular marker for the ERGIC [29]. ERGIC-53 is
expressed in all cells of multicellular organisms and there is a
non-essential yeast homolog known as Emp47p [30].
Selective protein transport from the ER requires transport
receptors. Recent evidence indicates that ERGIC-53 serves as
a transport receptor for some glycoproteins. ERGIC-53 pos-
sesses all the hallmarks of such a cargo receptor. First,
although predominantly localized to the ERGIC at steady
state [31], it constitutively recycles between ERGIC and ER
[27,28,32]. Second, ERGIC-53 possesses a V200 amino acid
segment in its luminal domain that shares homology with the
carbohydrate recognition domain of several plant lectins and
with the mammalian protein VIP36. ERGIC-53 and VIP36
were therefore proposed to de¢ne a new class of animal lectins
[33]. Mannose column chromatography showed that ERGIC-
53 is a mannose-selective lectin [34] but its precise lectin spe-
ci¢city remains to be established. Third, ERGIC-53 possesses
an ER exit determinant in its cytosolic domain that mediates
binding to COPII coats [35] (Fig. 2).
What are the cargo glycoproteins recognized by ERGIC-
53? If a cycling-impaired mutant of ERGIC-53 is mislocalized
to the ER of HeLa cells in a tetracycline-inducible manner,
intracellular transport of the lysosomal enzyme cathepsin C is
ine⁄cient suggesting that this enzyme is a ligand for ERGIC-
53 [36]. Interestingly, several mutations in human ERGIC-53
cause the bleeding disorder combined de¢ciency of coagula-
tion factors V and VIII [37^39]. Like cathepsin C, factors V
and VIII are ine⁄ciently transported if expressed in the ER-
GIC-53 cycling-impaired HeLa cell line [40] arguing that these
two coagulation factors are also ligands for ERGIC-53. A
mutant of ERGIC-53 in Drosophila, dubbed rhea, causes a
L-integrin-related developmental defect (J. Fristrom, personal
communication). Rhea is autosomal recessive and disrupts
integrin-dependent junctions in Drosophila both between
wing surfaces and between muscle and tendon cells resulting
in a blistered phenotype [41]. ERGIC-53 may therefore di-
rectly or indirectly a¡ect L-integrin tra⁄c. Inactivating ER-
GIC-53 by the RNAi approach in Caenorhabditis elegans
leads to an oocyte maturation defect (unpublished). It appears
Table 1
Lectins of the secretory pathway
Lectin Major localization Sugar speci¢city Ca2 dependence Function
Calnexin ER Gluc+Man + folding and degradation
Calreticulin ER Gluc+Man + folding and degradation
Man8 lectina ER Man8 ? degradation
ERGIC-53 ERGIC Man + ER-to-ERGIC transport
VIP36 cis-Golgi/ERGIC Man6ÿ9 3 retrieval?
Apical lectin(s)a TGN? Man? ? Golgi-to-plasma membrane transport
IGF-II/CI-MPRb late endosome Man-6-P 3 Golgi-to-endosome and plasma membrane-to-
endosome transport
CD-MPRc late endosome Man-6-P + Golgi-to-endosome transport
aSuch lectins have been postulated, but their identity is unknown.
bInsulin-like growth factor-II/cation-independent mannose 6-phosphate/receptor.
cCation-dependent mannose 6-phosphate receptor.
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Fig. 1. Lectin-mediated glycoprotein transport in the secretory pathway. After synthesis and removal of the two outermost glucose residues of
their N-glycans many glycoproteins bind to the ER lectins calnexin and/or calreticulin which recognize monoglucosylated N-glycans. Subse-
quently the glycoproteins are trimmed by glucosidase II (GlcII) and, if still incompletely folded (marked in white), reglucosylated by GT which
redirects them to another cycle of quality control. After prolonged residence time in the ER, ER mannosidase I (ER Man I) removes one man-
nose residue of the middle branch of the N-glycan. Incompletely folded, and thus reglucosylated, Man8 glycoproteins are targeted for calnexin-
dependent retrotranslocation to the cytosol and subsequent degradation by the proteasome. By contrast, correctly folded proteins (marked in
black) are no longer recognized by GT after deglucosylation by GlcII and are transport-competent. They may or may not undergo some addi-
tional trimming by mannosidase I and II before leaving the ER. Some of these Man7ÿ9 glycan-bearing proteins (*) now bind to the lectin ER-
GIC-53 which recruits them to COPII buds and thereby facilitates transport to the ERGIC. Dissociation of ERGIC-53 and its glycoprotein li-
gand occurs in the ERGIC and free ERGIC-53 recycles to the ER via COPI vesicles. In the cis-Golgi, glycoproteins are either trimmed to
Man5 prior to reglucosylation by Golgi glycosyltransferases, or tagged with the lysosomal signal Man-6-P by sequential action of phosphotrans-
ferase (PT) and phosphodiesterase (PD). Some glycoproteins escape cis-Golgi trimming but may be recognized by VIP36 in the trans-Golgi and
recycled to the cis-Golgi for another trimming attempt. Proteins carrying Man-6-P residues are recognized by MPRs in the trans-Golgi and
sorted to endosomes via clathrin-coated vesicles. Secreted Man-6-P-bearing glycoproteins can also be internalized from the plasma membrane
by the large MPR. N-Glycans also serve as signals for Golgi exit and apical targeting in epithelial cells. These processes may also be mediated
by lectins that are, however, unknown. ECV, endosomal carrier vesicles; EE, early endosome; LE, late endosome; TC, translocation channel.
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likely that in C. elegans ERGIC-53 a¡ects the transport of yet
other glycoproteins. Direct evidence for a transport receptor
function was obtained in hamster cell cultures by chemical
crosslinking [42]. These experiments identi¢ed a glycoprotein
related to human cathepsin Z as a ligand for ERGIC-53.
Cloning con¢rmed that this protein is indeed the hamster
homolog of human cathepsin Z, a close relative of cathepsin
C (unpublished). Thus, ERGIC-53 is the ¢rst identi¢ed cargo
receptor for protein transport from ER to ERGIC.
Collectively the experiments with ERGIC-53 suggest the
following mechanism (Fig. 1). ERGIC-53 recognizes glyco-
proteins carrying high-mannose N-glycans in the ER in a
calcium-dependent manner. Studies with deoxymannojirimy-
cin indicate that mannose trimming down to Man7 is not
required for binding to ERGIC-53. Although ERGIC-53 is
an oligomeric protein forming disul¢de-linked dimers and
hexamers the monomer can bind cargo glycoproteins in vivo
[42]. E⁄cient ER exit of ERGIC-53 is determined by a com-
plex interplay of numerous determinants including oligomeri-
zation [42], particular amino acids in the transmembrane do-
main (unpublished) and a C-terminal diphenylalanine ER exit
determinant (Fig. 2) [35]. Peptide binding studies in vitro in-
dicate that the diphenylalanine motif mediates binding to CO-
PII coat proteins which is the likely mechanism by which
ERGIC-53 is selectively recruited to COPII vesicles [35]. In
C. elegans the most C-terminal phenylalanine is replaced by
tyrosine and in yeast Emp47p the diphenylalanine motif is
replaced by two leucines suggesting that other hydrophobic
amino acids also mediate e⁄cient ER exit (Fig. 2). Dissocia-
tion of cargo occurs in the ERGIC by a mechanism that
remains to be elucidated, but mannose trimming is not re-
quired for dissociation [42]. After dissociation, ERGIC-53 re-
cycles to the ER in COPI vesicles, a process that is blocked by
numerous agents including brefeldin A [29]. ERGIC-53 pos-
sesses a dilysine ER targeting signal [43] that binds COPI
proteins [35,44] (Fig. 2).
While ERGIC-53 null mutations in humans apparently lead
to no other phenotype than reduced levels of the blood coag-
ulation factors V and VIII, the above mentioned experiments
with C. elegans and Drosophila, as well as with mammalian
cell cultures, indicate that ERGIC-53 also a¡ects the transport
of an increasing number of other glycoproteins. This raises the
question if other lectins can compensate for the lack of ER-
GIC-53. The only known homolog of ERGIC-53 is VIP36
(see below) but due to its di¡erent lectin properties and local-
ization it appears less likely that VIP36 can replace ERGIC-
53. If other lectins are responsible for this compensation they
would in all likelihood not be homologous to ERGIC-53.
Extrapolating from quality control in the ER in which calnex-
in/calreticulin-dependent processes can be compensated to
some extent by non-lectin chaperones it is conceivable that
the lack of ERGIC-53 can be compensated by other non-
lectin transport receptors mediating ER-to-Golgi transport.
The only other currently known transport receptor is
Emp24p in yeast [45]. A knock-out of the corresponding
gene in yeast delays transport of invertase and Gas1p and
de¢ciency of the Emp24p-related protein p23 in mice is em-
bryonically lethal [46]. Yet another possibility is that in nor-
mal cells e⁄cient transport of many glycoproteins is depen-
dent on ERGIC-53 and that ERGIC-53-defective cells would
largely bypass this requirement by increasing the synthesis of
the ERGIC-53-dependent glycoproteins. Close to normal
amounts of these proteins could therefore leave the ER by
bulk £ow. In that sense, ERGIC-53, and selective transport
from the ER in general, would function as an energy saver.
4. Sorting in the Golgi
The Golgi is the next sorting station in the secretory path-
way after the ERGIC. Sorting occurs all along the cis^trans
axis. It involves sorting of anterograde and retrograde tra⁄c
in cis-, medial-, and trans-cisternae as well as sorting to post-
Golgi compartments in the trans-Golgi network (TGN)
[47,48]. A putative sorting lectin is the type I integral mem-
brane glycoprotein VIP36 (Table 1). VIP36 is homologous to
ERGIC-53, and was initially thought to cycle between TGN
and plasma membrane [49]. More recent immuno£uorescence
studies suggest, however, localization to cis-Golgi and some
ERGIC elements, and previous cell surface localization is now
believed to be non-physiological due to overexpression [50].
At steady state there is overlap but not identity with the local-
ization of ERGIC-53, but the patterns of the two proteins
entirely merge after brefeldin A treatment suggesting that
VIP36 recycles between Golgi and ERGIC [50]. Distribution
of VIP36 more to the Golgi may be due to the fact that VIP36
lacks a cytosolic dilysine ER retention/retrieval signal [49,51]
(Fig. 2). Unlike (arti¢cially) glycosylated ERGIC-53, VIP36
rapidly acquires endoglycosidase H resistance in pulse-chase
experiments indicating that the protein has access to the me-
dial-Golgi and presumably recycles from all levels of the Gol-
gi. However, no recycling motif has been identi¢ed yet. The
lectin speci¢city of VIP36 has been studied in detail [52,53].
VIP36 shows speci¢city for high-mannose type glycans of the
Man6ÿ9GlcNAc2 structure but e⁄cient binding requires the
additional presence of an K-substituted asparagine residue.
Contrary to ERGIC-53, VIP36 does not require calcium for
ligand binding [50], and it may also recognize GalNAc resi-
dues [54].
The function of VIP36 is currently unknown. Collectively,
the features of VIP36 suggest a function in quality control in
the Golgi. We speculate (Fig. 1) that VIP36 recognizes glyco-
Fig. 2. Targeting motifs in the cytosolic domain of the tra⁄c lectins
ERGIC-53 and VIP36. ER exit determinants are bold-faced and the
ER-targeting dilysine signal is underlined. Numbering is from the
carboxy-terminal end with the last amino acid indicated as 31.
Note that both proteins have an ER exit determinant but only ER-
GIC-53 also possesses a dilysine signal operating in COPI vesicle-
mediated retrograde transport.
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proteins that have escaped glycan trimming by cis-Golgi man-
nosidase I to the Man5GlcNAc2 structure and recycles them
back for an additional round of trimming. Due to the slightly
acidic pH optimum VIP36 binding to incorrectly trimmed
cargo, and hence retrieval e⁄ciency, would increase from
cis- to trans-Golgi. This would make sense because correct
trimming by Golgi mannosidase I may be possible at least
up to the medial-Golgi [55]. Once correctly trimmed, the gly-
coproteins can no longer bind to VIP36 and move on in the
secretory pathway.
Lectins also play a role in glycoprotein exit from the Golgi.
As mentioned in Section 1, MPRs are the paradigm for tra⁄c
lectins in the secretory pathway [56,57]. Two MPRs are
known (Table 1). Both are type I integral membrane proteins
and constitute the P-type family of animal lectins. The 275
kDa cation-independent MPR also binds insulin-like growth
factor (IGF) II. The 46 kDa receptor requires cations for li-
gand binding. Both receptors recognize Man-6-P-modi¢ed ly-
sosomal hydrolases in the TGN and sort them into clathrin-
coated vesicles destined for endosomes (Fig. 1). In the acidi-
¢ed endosomes the enzymes dissociate and undergo dephos-
phorylation. Hydrolases bearing glycans with two Man-6-P
residues show about 10-fold higher binding than those with
a single Man-6-P residue which is in line with the dimeric
nature of the receptors [58,59]. Both receptors have access
to the plasma membrane but only the large MPR can internal-
ize lysosomal enzymes and IGF II. Knock-out experiments in
mice indicate that each MPR has distinct but overlapping
functions for the targeting of lysosomal enzymes in vivo
[57,60]. Tra⁄cking of the MPRs depends on numerous sorting
signals in the cytosolic domain of the proteins that determine
Golgi exit, internalization at the plasma membrane and recy-
cling from endosomes [57,61^63]. MPR recycling from endo-
somes to the TGN is clathrin-independent but the nature of
the transport carrier is unknown.
Studies with polarized epithelial cells suggest that lectins
may be involved in glycoprotein transport from the Golgi to
the apical cell surface [64]. Apical targeting has been attrib-
uted to di¡erent types of sorting signals, including N-linked
and O-linked carbohydrates [65]. Introduction of N-glycosyl-
ation sites into non-glycosylated soluble or membrane pro-
teins can target them to the apical cell surface indicating
that N-glycans operate as apical targeting signals [66,67]. Ba-
solateral targeting determinants are generally dominant over
the apical glycan signal. In the absence of speci¢c sorting
signals, transmembrane proteins accumulate in the Golgi sug-
gesting that exit from the Golgi is signal-mediated. It is inter-
esting to note that N-glycans also mediate Golgi exit in non-
polarized cells [67]. It is conceivable therefore that membrane
lectins sort glycoproteins into transport vesicles in the TGN
(Fig. 1), but such lectins remain to be discovered. Because this
sorting process does not require complex glycosylation (K.
Matter, unpublished) one would predict that the postulated
Golgi lectins recognize the Man-GlcNAc core of glycopro-
teins. VIP36 was initially postulated as a candidate for apical
glycoprotein sorting [49,53] but because VIP36 is localized to
the early rather than the late secretory pathway [50] such a
function now appears less likely.
5. Conclusions
Lectins play important roles in quality control and protein
tra⁄c along the secretory pathway. The studies with ERGIC-
53 point to a novel function of lectins in the secretory path-
way: facilitation of glycoprotein transport from ER to ER-
GIC. Although lectin-dependent transport from the ER would
be a conceptually striking general solution for selective trans-
port of all glycoproteins it appears that only a limited set of
glycoproteins depend on ERGIC-53. It is currently unknown
if there are other lectins that can also operate as receptors for
glycoprotein transport from ER to Golgi. Other challenges for
the future include the elucidation of the mechanism by which
ERGIC-53 recognizes glycoprotein cargo in a selective way,
the determination of the role of VIP36 in the secretory path-
way and the search for the postulated lectins mediating Golgi
exit. This research is likely to have an impact on understand-
ing fundamental mechanisms underlying selective protein
transport and sorting in the secretory pathway in health and
disease. An increasing number of inherited or acquired dis-
eases are due to ine⁄cient secretion of key molecules. Under-
standing the molecular basis of these defects may lead to the
development of new strategies for the treatment of these dis-
eases.
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